Drugs / T-Rapa
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00074490 | Jan 2004 → Jul 2017 | leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, plasma cell myeloma | National Cancer Institute (NCI) | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T-Rapa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00074490 ↗ |
| Modality | Cell therapy | “T-Rapa cell products, which expressed a balanced Th2/Th1 phenotype” PMID 23426943 ↗ Feb 2013 |